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ABSTRACT 
Background: Neurofibromatosis type 1 (NF1) is a common genetic disorder that 
manifests in early childhood. Although not a classical manifestation, NF1 has been associated 
with sleep problems in children, which could have a major impact in their day-to-day life and 
compromise their future. We set out to assess whether there is a higher prevalence of sleep 
disturbances in children with NF1, as compared to children without the disease. 
Methods: We applied the Portuguese version of the Children’s Sleep Habits 
Questionnaire (CSHQ) in order to evaluate the sleep quality of children aged 2-10 years old. 
The CSHQ was distributed in primary schools and preschools throughout the country and also 
via e-mail to the members of the Portuguese Neurofibromatosis Association. We divided the 
participants into the NF1 group and the control group, based on whether they had been 
diagnosed with NF1 or not, and compared the results with standard statistical analysis. 
Results: We observed no difference in the CSHQ Total Score between groups 
(p=0.176). However, we did find higher scores in the NF1 group in the subscales Sleep 
Duration (p=0.006), Night Wakings (p=0.041) and Sleep-Disordered Breathing (p=0.009), 
compared to the controls. We also found Sleep Duration (AUROC=0.690; p=0.018) and 
Sleep-Disordered Breathing (AUROC=0.677; p=0.028) subscales to have predictive value for 
the NF1 group, more so when combined. 
Discussion: We observed a higher prevalence of specific sleep disturbances in children 
with NF1, although not a global sleep impairment. We hypothesize that these findings are 
consistent with the notion that sleep disturbances are associated with a dysfunctional default 
mode network (DMN) in individuals with NF1. 
 
Keywords: Children's Sleep Habits Questionnaire; Cross-Sectional Studies; Default 
Mode Network; Neurofibromatosis 1; Sleep Disorders. 
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RESUMO 
Introdução: A neurofibromatose do tipo 1 (NF1) é uma doença genética relativamente 
comum que se manifesta na infância precoce. Embora não seja um sintoma clássico, a NF1 
foi associada a problemas de sono em crianças, que podem ter um impacto negativo no seu 
dia-a-dia e prejudicar o seu futuro. No presente estudo, nós propusemo-nos a averiguar se 
haverá uma maior prevalência de distúrbios do sono em crianças com NF1, relativamente a 
crianças sem a doença. 
Métodos: Aplicámos a versão portuguesa do Children’s Sleep Habits Questionnaire 
(CSHQ) para avaliar a qualidade do sono de crianças com idades compreendidas entre 2-10 
anos. O CSHQ foi distribuído em escolas primárias e jardins-escola pelo país e também via 
correio electrónico para os membros da Associação Portuguesa de Neurofibromatose. 
Dividimos os participantes em dois grupos, o grupo NF1 e o grupo de controlo, consoante 
tinham ou não sido diagnosticados com NF1, e comparámos estatisticamente os resultados. 
Resultados: Não encontrámos diferenças na Pontuação Total do CSHQ entre grupos 
(p=0.176). No entanto, observámos pontuações mais elevadas no grupo NF1 nas subescalas 
Duração do Sono (p=0.006), Despertares Nocturnos (p=0.041) e Perturbação Respiratória do 
Sono (p=0.009), relativamente aos controlos. Também verificámos que as subescalas Duração 
do Sono (AUROC=0.690; p=0.018) e Perturbação Respiratória do Sono (AUROC=0.677; 
p=0.028) têm capacidade preditiva para o grupo NF1, com maior efeito quando combinadas. 
Discussão: Observámos uma maior prevalência de perturbações do sono específicas em 
crianças com NF1, mas não uma perturbação generalizada do sono. Nós especulamos que 
estes achados são consistentes com a noção de que as perturbações do sono estão associadas à 
disfunção da default mode network (DMN) em indivíduos com NF1. 
Palavras-chave: Children’s Sleep Habits Questionnaire; Estudo Transversal; Default Mode 
Network; Neurofibromatose 1; Distúrbios do Sono.  
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ACRONYMS 
 
ADHD Attention deficit/hyperactivity disorder 
AUROC Area under ROC curve 
CSHQ Children’s Sleep Habits Questionnaire 
DMN  Default-mode network 
fMRI Functional Magnetic Resonance Imaging 
NF1 Neurofibromatosis type 1 
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BACKGROUND 
Neurofibromatosis type 1 (NF1) is a common genetic disorder that affects 1 in 3000 to 
3500 people.[1] It is caused by a mutation in the NF1 gene, located on chromosome 17, that 
can be inherited in an autosomal dominant pattern or emerge as a de novo mutation.[2] NF1 
has a penetrance of 100% by the age of twenty years,[1] but its expression is highly 
variable.[3] More than 1485 mutations have been identified but no clear link between 
genotype and phenotype has been established, save rare exceptions. The NF1 gene encodes 
the protein neurofibromin, which has an important role in the regulation of cell growth and 
proliferation, acting as a tumor suppressor through the inhibition of RAS signal transduction 
pathway. The impaired expression of neurofibromin in NF1 results in unrestricted cell 
proliferation and is, therefore, associated with an increased risk of tumor formation.[2,3] 
NF1 frequently manifests in early childhood and its diagnosis is essentially clinical.[1] 
Common manifestations include café-au-lait spots, inguinal and/or axillary freckling, iris 
hamartomas (Lisch nodules), neurofibromas, optic pathway gliomas, skeletal and 
cardiovascular deformities and neurocognitive deficits. The latter are extremely frequent in 
individuals with NF1 and they represent a major impediment in day-to-day life.[1,4] Several 
studies [5,6] have shown a predominance of specific difficulties in different areas of cognition 
rather than a global intellectual deficit in individuals with NF1, namely language, memory 
and attention problems, visuospatial perception impairment, executive functioning deficits, 
among others. A higher prevalence of attention deficit/hyperactivity disorder (ADHD) and 
autism spectrum disorders has also been described. In affected children, cognitive deficits 
have a negative impact on school performance, social development and emotional adjustment, 
potentially jeopardizing their academic future and overall quality of life.[5,6] 
Sleep disturbances are not classically considered manifestations of NF1. Johnson et 
al.[7] found a higher prevalence of sleep problems in children with NF1, however, no recent 
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studies have been dedicated to clarifying this relationship. Sleep disturbances can manifest in 
children as excessive daytime sleepiness, poor concentration, decreased attention, depressed 
mood, behavioral problems, learning difficulties and poor academic performance.[8] As 
several of these symptoms can also appear in children with NF1, concomitant sleep 
disturbances in these individuals may exacerbate preexisting cognitive deficits and, if 
unrecognized or untreated, could worsen the child’s prognosis. It is, therefore, of vital 
importance to ascertain whether the occurrence of sleep problems is directly related to NF1 
and, if so, how it may affect the patients’ everyday life. 
The purpose of this study is to assess whether there is a higher prevalence of sleep 
disturbances in children with NF1, when compared to children without the disease. 
 
METHODS 
Enrollment of Participants 
Children between the ages of 2 and 10 years old were randomly selected from two 
primary schools and two preschools in different regions of Portugal (Portalegre, Braga and 
Leiria). One-hundred and seventeen questionnaires were delivered to the parents of these 
children through their class teachers, from the 2-year-old class in preschools to the 4
th
 grade 
class in primary schools, with the authorization of the respective school directors. Ninety 
questionnaires (76.9%) were returned, from which 16 were incomplete and 5 matched 
exclusion criteria. The 69 remaining questionnaires (59.0%) were included in the study. The 
questionnaires were distributed and received from May 15
th
 2014 until July 30
th
 2014. 
An online version of the questionnaire was disclosed through the mailing list of the 
Portuguese Neurofibromatosis Association (Associação Portuguesa de Neurofibromatose) in 
order to recruit subjects for the NF1 study group. There were 20 replies, from which two did 
not fit the age range and two matched exclusion criteria. The 16 remaining questionnaires 
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were included in the study. The online questionnaire was made available on July 8
th
 2014 and 
replies were received until August 30
th
 2014. 
Inclusion and Exclusion Criteria 
The inclusion criteria considered were the child’s age, from 2 through 10 years old, and 
the consent from the parents or legal guardians. The selection of the NF1 study group was 
based on the child’s Neurofibromatosis type 1 diagnosis reported by the parents. This study 
was within the scope of grant PTDC/SAU-ORG/118380/2010 and its ethical approval. 
The exclusion criteria included medications or conditions that might impact the quality 
or pattern of sleep, such as ADHD, autism spectrum disorders, complex neurological 
disorders, psychiatric disorders and unstable chronical disorders (e.g., epilepsy, asthma). All 
seven cases that matched exclusion criteria involved the regular use of potentially sleep-
altering medication (e.g., Singulair®, Xyzal®, Rubifen®, Zyrtec®, Risperdal®, Tegretol®). 
Participants’ characteristics and sleep environment 
Information concerning the participants’ family sociodemographic characteristics and 
regarding the children’s sleep environment and routine was collected through a series of 
questions included in the questionnaire delivered to the parents (Attachment A). 
Children’s Sleep Habits Questionnaire 
In order to evaluate the sleep quality of children with and without Neurofibromatosis 
type 1, the Portuguese version of Owens’ “Children’s Sleep Habits Questionnaire” 
(CSHQ)[9,10] was applied (Attachment A). The CSHQ is a retrospective parent-report of the 
child’s sleep habits in a typical recent week. It is composed of 33 items, each scoring from 1 
to 3, which can be grouped into eight basic sleep domains: Bedtime Resistance, Sleep Onset 
Delay, Sleep Duration, Sleep Anxiety, Night Wakings, Parasomnias, Sleep-Disordered 
Breathing and Daytime Sleepiness. 
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The Total Score (i.e., the combined score of the 33 items) translates the global quality 
of sleep.  Higher scores are indicative of a more disturbed sleep, and vice-versa. In the 
original study,[9] a cut-off score of 41 was determined to have diagnostic value in identifying 
children with sleep disorders. The Portuguese validation study [10] concluded that the 
Portuguese version of the CSHQ showed acceptable psychometric properties for the screening 
of sleep problems in children aged 2 through 10 years old. 
Statistical Analysis 
The data analysis was performed using SPSS Statistics 17.0 program. The significance 
level was established at p < 0.05. Statistical descriptions comprised the mean, standard 
deviation and median for quantitative variables, and frequencies and percentages for nominal 
variables. T-Student and Mann-Whitney U tests were used to compare means of continuous 
variables such as age and CSHQ scores. Chi-square test, Fisher’s Exact Test and Montecarlo 
correction were used to compare frequencies of categorical sociodemographic and sleep 
related factors. ROC curve analysis was used to assess the predictive value of CSHQ Total 
Score and subscales for the NF1 group. Associations between CSHQ subscales were 
determined using Spearman’s correlation analysis. Logistic regression was applied in order to 
calculate odds ratios. 
 
RESULTS 
Participants’ sociodemographic characteristics, sleep environment and sleep 
routine 
As depicted in Table 1, 86 children participated in the present study. They were divided 
into the control group (n=70, 35 girls and 35 boys) and the NF1 group (n=16, 7 girls and 9 
boys). The age and gender of participants did not differ between groups, nor did the parent’s 
age, level of education, marital status and employment situation. 
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Table 1 - Sociodemographic characterization 
Variables Control group NF1 group P value 
 
n=70 n=16 
 Gender 
  
0.652
‡
 
Male 35 (50.0) 9 (56.3) 
 Female 35 (50.0) 7 (43.8) 
 Age 
   Participant 5.83 ± 2.467 4.56 ± 2.220 0.064
†
 
Mother 36.90 ± 5.754 34.56 ± 4.761 0.123
†
 
Father
1
 37.96 ± 5.371 35.56 ± 6.055 0.121* 
Parents’ marital status 
  
1.000
§
 
Married / civil union 61 (87.1) 14 (87.5) 
 Divorced 5 (7.1) 1 (6.3) 
 Single mother / father 4 (5.7) 1 (6.3) 
 Mother’s work status 
  
0.450
§
 
Unemployed 10 (14.3) 3 (18.8) 
 Part-time work 7 (10.0) 0 (0.0) 
 Full-time work 53 (75.7) 13 (81.3) 
 Father’s work status 
  
1.000
§
 
Unknown 2 (2.9) 0 (0.0)  
Unemployed 5 (7.1) 1 (6.3) 
 Part-time work 1 (1.4) 0 (0.0) 
 Full-time work 62 (88.6) 15 (93.8) 
 Mother’s education 
  
0.856
†
 
Basic education 12 (17.1) 3 (18.8) 
 Secondary education 26 (37.1) 5 (31.3) 
 Higher education 32 (45.7) 8 (50.0) 
 Father’s education1 
  
0.381
†
 
Basic education 20 (29.4) 3 (18.8) 
 Secondary education 28 (41.2) 7 (43.8) 
 Higher education 20 (29.4) 6 (37.5) 
 The data are presented as number (%) or mean ± standard-deviation. 
1In “Age - Father” and “Father’s education”, sample size in the control group is n=68 
*T-Student Test 
† Mann-Whitney U Test 
‡ Chi-Square Test 
§ Chi-Square Test with Monte-Carlo Correction 
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The children’s sleep environment was similar in both groups, with no differences 
regarding the type of residence, siblings, room sharing and co-sleeping. However, there was a 
difference in the population density of the participants’ area of residence, as all children in the 
NF1 group lived in urban settings (Table 2). 
 
Table 2 - Sleep environment 
Variables Control group NF1 group P value 
 n=70 n=16  
Residence 
  
0.313
§
 
Apartment 46 (65.7) 13 (81.3) 
 Row house 7 (10.0) 2 (12.5) 
 Unattached house 17 (24.3) 1 (6.3) 
 Population density < 0.001
‡
 
Rural (≤100/Km2) 40 (57.1) 0 (0.0)  
Urban (>100/Km
2
) 30 (42.9) 16 (100.0)  
Child has siblings 
  
0.236
‡
 
No 28 (40.0) 9 (56.3) 
 Yes 42 (60.0) 7 (43.8) 
 Child has single room 
  
0.309** 
No 4 (5.7) 2 (12.5) 
 Yes 66 (94.3) 15 (87.5) 
 Falls asleep on parent’s bed 
  
0.505** 
No 53 (75.7) 14 (87.5) 
 Yes 17 (24.3) 2 (12.5) 
 
The data are presented as number (%) or mean ± standard-deviation. 
**Fisher’s Exact Test 
‡ Chi-Square Test 
§ Chi-Square Test with Monte-Carlo Correction 
 
Children with NF1 were reported to wake up earlier, both in week days and in the 
weekend, and take naps more frequently than children in the control group, however, reported 
total sleep time was similar. There were no statistical differences concerning other sleep 
routines between groups (Table 3). 
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Table 3 - Sleep routine 
Variables Control group NF1 group P value 
 
n = 70 n = 16 
 Child has bedtime routine 
  
0.116** 
No 4 (5.7) 3 (18.8) 
 Yes 66 (94.3) 13 (81.3) 
 Child takes naps   0.014** 
No 54 (77.1) 7 (43.8)  
Yes 16 (22.9) 9 (56.3)  
Who puts the child to bed 
  
0.249
§
 
Father 3 (4.3) 2 (12.5) 
 Mother 30 (42.9) 3 (18.8) 
 Both parents 23 (32.9) 8 (50.0) 
 Child goes by him/herself 11 (15.7) 3 (18.8) 
 Other 3 (4.3) 0 (0.0) 
 Parents are present when child falls asleep 0.652
‡
 
No 35 (50.0) 7 (43.8) 
 Yes 35 (50.0) 9 (56.3) 
 Bedtime 
   Week 21:40h ± 34m 21:46h ± 39m 0.476
†
 
Weekend 22:24h ± 41m 22:19h ± 44m 0.538
†
 
Wake time 
   Week 7:50h ± 28m 7:23h ± 59m 0.001
†
 
Weekend 9:00h ± 58m 8:11h ± 82m 0.010
†
 
Total daily sleep time (including 
naps) 
10.33h ± 1.156 10.19h ± 1.548 0.565
†
 
The data are presented as number (%) or mean ± standard-deviation. 
**Fisher’s Exact Test 
† Mann-Whitney U Test 
‡ Chi-Square Test 
§ Chi-Square Test with Monte-Carlo Correction 
 
The parents were asked whether they were concerned about their child’s quality of sleep 
(Figure 1) and the answers differed between the control group and the NF1 group, revealing a 
greater concern about sleep problems from parents of children with NF1 (p = 0.006). 
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Figure 1 - Comparison of parents’ concern with child’s sleep between NF1 and 
control groups 
 
 
The Children’s Sleep Habits Questionnaire 
We analyzed the results of the CSHQ, comparing the scores of the NF1 group with the 
ones reported by the control group. 
The Total Score did not differ statistically between the NF1 group and the control group 
(p=0,176), but we observed a tendency for higher scores in the NF1 group (Table 4). 
When evaluating the CSHQ subscales, we found that Sleep Duration (p=0,006), Night 
Wakings (p=0,041) and Sleep-Disordered Breathing (p=0,009) scores were significantly 
higher in the NF1 group than in the control group. No differences were observed in the 
subscales Bedtime Resistance (p=0.330), Sleep Onset Delay (p=0.680), Sleep Anxiety 
(p=0.742), Parasomnias (p=0.125) or Daytime Sleepiness (p=0.057) between groups. 
Analyzing the items that compose Sleep Duration, Night Wakings and Sleep-Disordered 
Breathing, we found that, in the NF1 group, children were more frequently reported to sleep 
scantily (item 9, p<0.001), to have an irregular sleep duration (item 11, p=0.034), to wake up 
once or more during the night (item 24, p=0.037, and item 25, p=0.001), to snore loudly (item 
18, p=0.007) and to experience sleep apneas (item 19, p=0.039), when compared to controls. 
 
0% 
20% 
40% 
60% 
80% 
100% 
NF1 group Control group 
No 
Yes 
Are parents concerned 
about child's sleep? 
56.3% 
43.8% 
88.6% 
11.4% 
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Table 4 - Children’s Sleep Habits Questionnaire 
CSHQ Control group NF1 group P value 
 
n = 70 n = 16 
 Total Score 46.5 ± 6.449 49.0 ± 7.303 0.176* 
Subscales 
   Bedtime Resistance 8.81 ± 3.013 [8.0] 9.31 ± 2.600 [9.0] 0.330† 
Sleep Onset Delay 1.76 ± 0.859 [1.0] 1.63 ± 0.719 [1.5] 0.680† 
Sleep Duration 3.49 ± 0.913 [3.0] 4.56 ± 1.750 [4.0] 0.006† 
Sleep Anxiety 6.04 ± 1.899 [6.0] 5.88 ± 1.821 [5.5] 0.742† 
Night Wakings 3.83 ± 1.154 [3.0] 4.56 ± 1.504 [4.5] 0.041† 
Parasomnias 9.01 ± 1.655 [9.0] 9.88 ± 2.029 [10.0] 0.125† 
Sleep-Disordered Breathing 3.60 ± 1.345 [3.0] 4.44 ± 1.825 [4.0] 0.009† 
Daytime Sleepiness 13.16 ± 2.981 [13.0] 11.56 ± 1.931 [12.0] 0.057† 
The data are presented as mean ± standard-deviation or  mean ± standard-deviation [median] 
* T-Student Test 
† Mann-Whitney U Test 
 
The ROC curve analysis showed us that the subscales Sleep Duration (AUROC=0.690; 
p=0.018) and Sleep-Disordered Breathing (AUROC=0.677; p=0.028) had predictive value for 
the NF1 group (Table 5), thus strengthening the association between these altered sleep 
domains and NF1. We found no correlation between these two subscales (p=0.279), using 
Spearman’s correlation analysis. Hence, we set out to analyze the separate and combined 
capability of these subscales in predicting the NF1 group, using logistic regression and ROC 
curve analysis. The odds ratios are described in Table 6. We noticed that the combined score 
of Sleep Duration and Sleep-Disordered Breathing (Table 5) had a greater predictive value for 
the NF1 group (AUROC=0.783; p<0.001) than that of the isolated subscales. 
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Table 5 - Predictive value of CSHQ Total Score and 
subscales for NF1 group 
CSHQ NF1 group 
AUROC* P value 
Total Score 0.628 0.111 
Bedtime Resistance 0.577 0.340 
Sleep Onset Delay 0.470 0.706 
Sleep Duration 0.690 0.018 
Sleep Anxiety 0.474 0.748 
Night Wakings 0.652 0.059 
Parasomnias 0.621 0.131 
Sleep-Disordered Breathing 0.677 0.028 
Daytime Sleepiness 0.348 0.058 
Sleep Duration + Sleep-
Disordered Breathing 
0.783 <0.001 
* AUROC  - area under ROC curve  
 
Table 6 - Association between Sleep Duration and Sleep-
Disordered Breathing and the diagnosis of NF1 
CSHQ Odds Ratio P value 
Sleep Duration 1.860 0.004 
Sleep-Disordered Breathing 1.353 0.075 
  
 
DISCUSSION 
We set out to explore the occurrence of sleep problems in children with NF1, comparing 
with controls. As we expected, we found a higher prevalence of sleep disturbances in specific 
sleep domains in children with NF1, although not a global sleep impairment. The affected 
sleep domains were Sleep Duration, Sleep-Disordered Breathing and, to a lesser extent, Night 
Wakings. The disturbance of specific sleep domains fits the NF1 clinical profile, similarly to 
the neurocognitive manifestations which usually comprise specific deficits rather than a 
global impairment. 
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We hypothesize that both these conditions, NF1 and sleep disturbances, may be 
connected through an underlying mechanism - a dysfunction of the default mode network 
(DMN). The DMN is a neuronal network which is primarily active when the brain is at rest 
(task-negative state), promoting self-referential thought (i.e., internal mentation, 
daydreaming), and deactivates during cognitive demanding tasks.[11,12] DMN dysfunction, 
whether through excessive activation or inadequate deactivation, may result in impaired 
cognitive performance and has been shown to be involved in several neuropsychological 
disorders.[12] 
Recent studies have proposed the involvement of the DMN both in NF1 and in 
insomnia. Violante et al.[13] discovered a dysfunction in the DMN in patients with NF1, 
theorizing its involvement in the pathogenesis of the cognitive deficits frequently found in 
these individuals. On the other hand, Marques et al.[14] suggested a contributing role of 
DMN dysfunction in the onset and maintenance of insomnia. 
Thus, we believe DMN dysfunction to be a primary physiopathological process in NF1, 
possibly underlying an increased prevalence of specific sleep disorders in affected children. 
Limitations 
A major limitation of the present study is the sample size of the NF1 group. A target 
enrollment of 26 children for the NF1 group and 26 for the control group was projected, 
derived from a sample-size calculation using α = 0.05, power of 0.80 and a large effect size. 
However, only 16 participants were gathered in the NF1 group, lowering the power of the 
study to only about 0.43. 
Another limitation is the reliance on the parents’ report alone to evaluate sleep quality, 
while other methods, such as polysomnography, would allow for a more objective and 
accurate assessment of sleep. 
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Also, we cannot exclude environmental factors, such as the population density of the 
participants’ area of residence, as a source of bias. 
Future directions 
We believe this subject warrants a deeper investigation, through a more detailed 
analysis of sleep using polysomnography in children with NF1 and a proper 
neuropsychological evaluation in order to characterize cognitive deficits, assess their severity 
and impact in the children’s lives, and expose their association with disturbed sleep. 
We also believe it would be valuable to further explore the role of DMN dysfunction in 
the physiopathology of NF1 and its association with cognitive deficits and sleep disturbances, 
using functional neuroimaging techniques such as fMRI. 
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